Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Mark J, Lee"'
Autor:
Jon M. Johannesson, William A. Glover, Cathy A. Petti, Timothy H. Veldman, Ephraim L. Tsalik, Donald H. Taylor, Stephanie Hendren, Coralei E. Neighbors, L. Gayani Tillekeratne, Scott W. Kennedy, Barrie Harper, Warren A. Kibbe, Giselle Corbie, Michael Cohen-Wolkowiez, Christopher W. Woods, Mark J. Lee
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionThe COVID-19 pandemic focused attention on healthcare disparities and inequities faced by individuals within marginalized and structurally disadvantaged groups in the United States. These individuals bore the heaviest burden across this p
Externí odkaz:
https://doaj.org/article/5a828f3a2e9441c1b4378e4869552c09
Autor:
Mary K Hayden, Kimberly E Hanson, Janet A Englund, Francesca Lee, Mark J Lee, Mark Loeb, Daniel J Morgan, Robin Patel, Abdallah El Alayli, Ibrahim K El Mikati, Shahnaz Sultan, Yngve Falck-Ytter, Razan Mansour, Justin Z Amarin, Rebecca L Morgan, M Hassan Murad, Payal Patel, Adarsh Bhimraj, Reem A Mustafa
Publikováno v:
Clinical Infectious Diseases.
Background Immunoassays designed to detect SARS-CoV-2 protein antigens (Ag) are commonly used to diagnose COVID-19. The most widely used tests are lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-car
Autor:
Patrick C Tam, Barbara D Alexander, Mark J Lee, Rochelle G Hardie, John M Reynolds, John C Haney, Ken B Waites, Arthur W Baker
Publikováno v:
Open Forum Infectious Diseases. 9
Background Mollicutes, such as Mycoplasma hominis and Ureaplasma spp, are fastidious bacteria that can cause invasive donor-derived infections in lung transplant recipients. Best practices for donor screening and recipient surveillance for Mollicute
Autor:
Mark J Lee
Publikováno v:
Expert Review of Molecular Diagnostics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged as a novel viral agent that quickly spread worldwide. SARS-CoV-2 is responsible for the human coronavirus disease 2019 (COVID-19) which has claimed hundreds of tho
Autor:
Mark J. Lee, Alexander M. Geller, Natalie C. Bamford, Hong Liu, Fabrice N. Gravelat, Brendan D. Snarr, François Le Mauff, Joseé Chabot, Benjamin Ralph, Hanna Ostapska, Mélanie Lehoux, Robert P. Cerone, Stephanie D. Baptista, Evgeny Vinogradov, Jason E. Stajich, Scott G. Filler, P. Lynne Howell, Donald C. Sheppard
Publikováno v:
mBio, Vol 7, Iss 2 (2016)
ABSTRACT The mold Aspergillus fumigatus causes invasive infection in immunocompromised patients. Recently, galactosaminogalactan (GAG), an exopolysaccharide composed of galactose and N-acetylgalactosamine (GalNAc), was identified as a virulence facto
Externí odkaz:
https://doaj.org/article/ca26861971b54fcea0b6f4b5258f1164
Autor:
Holly K. Huse, John J. LiPuma, Maria M. Traczewski, Peter Jorth, Mark J Lee, Susan E. Sharp, Mandy Wootton
Publikováno v:
J Clin Microbiol
The Burkholderia cepacia complex (BCC) is known for causing serious lung infections in people with cystic fibrosis (CF). These infections can require lung transplantation, eligibility for which may be guided by antimicrobial susceptibility testing (A
Autor:
Mark J Lee, Hong Liu, Bridget M Barker, Brendan D Snarr, Fabrice N Gravelat, Qusai Al Abdallah, Christina Gavino, Shane R Baistrocchi, Hanna Ostapska, Tianli Xiao, Benjamin Ralph, Norma V Solis, Mélanie Lehoux, Stefanie D Baptista, Arsa Thammahong, Robert P Cerone, Susan G W Kaminskyj, Marie-Christine Guiot, Jean-Paul Latgé, Thierry Fontaine, Donald C Vinh, Scott G Filler, Donald C Sheppard
Publikováno v:
PLoS Pathogens, Vol 11, Iss 10, p e1005187 (2015)
Of the over 250 Aspergillus species, Aspergillus fumigatus accounts for up to 80% of invasive human infections. A. fumigatus produces galactosaminogalactan (GAG), an exopolysaccharide composed of galactose and N-acetyl-galactosamine (GalNAc) that med
Externí odkaz:
https://doaj.org/article/b6d5e976b224466ca13478d65ff74e9e
Autor:
Kimberly E. Hanson, Valery Lavergne, Payal M. Patel, Mark Loeb, Cesar A. Arias, Osama Altayar, Razan Mansour, Angela M. Caliendo, Mark J Lee, Yngve Falck-Ytter, Shahnaz Sultan, Janet A. Englund, Reem A. Mustafa, M. Hassan Murad, Robin Patel, Adarsh Bhimraj, Rebecca L. Morgan, Abdallah El Alayli, Mary K. Hayden
Publikováno v:
Clinical Infectious Diseases.
Immunoassays designed to detect SARS-CoV-2 protein antigens are now commercially available. The most widely used tests are rapid lateral flow assays that generate results in ~15 minutes for diagnosis at the point-of-care. Higher throughput, laborator
Autor:
Kimberly E, Hanson, Osama, Altayar, Angela M, Caliendo, Cesar A, Arias, Janet A, Englund, Mary K, Hayden, Mark J, Lee, Mark, Loeb, Robin, Patel, Abdallah, El Alayli, Shahnaz, Sultan, Yngve, Falck-Ytter, Valery, Lavergne, Razan, Mansour, Rebecca L, Morgan, M Hassan, Murad, Payal, Patel, Adarsh, Bhimraj, Reem A, Mustafa
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Immunoassays designed to detect SARS-CoV-2 protein antigens are now commercially available. The most widely used tests are rapid lateral flow assays that generate results in approximately 15 minutes for diagnosis at the point-of-care. Higher throughp
Autor:
Gavin Martin, Christopher R. Polage, Catherine Rehder, Jessica Seidelman, Becky Smith, Thomas N. Denny, Ibukunoluwa C. Akinboyo, Mark J Lee, Bruce Lobaugh, Michael B. Datto, Sarah S. Lewis, Diana M. Cardona, Cameron R. Wolfe, Allan B Kirk
Publikováno v:
Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
Infection Control & Hospital Epidemiology
We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (CO